BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 18, 2008
View Archived Issues
Antiviral effects of rapamycin in mouse model of HIV infection
Read More
SRI-21950 active against vaccinia and cowpox viruses in mice
Read More
Lexicon presents early clinical results of LX-6171 at the AAN meeting
Read More
Proposed merger between Inflazyme and Z-Tech is terminated
Read More
Fusion construct targeting carcinoembryonic antigen cytotoxic in vitro
Read More
XIAP knockdown allows cancer cell apoptosis with TRAIL in resistant cells
Read More
New farnesoid X receptor agonist shows preclinical potential in dyslipidemia
Read More
FDA accepts Huya's IND-enabling nonclinical and clinical development plans for chidamide
Read More
E.U. approves new powerful antihypertensive MicardisPlus 80/25
Read More
Kythera commences second phase II ATX-101 trial for reduction of submental fat
Read More
Pfizer completes tender offer for shares of Encysive
Read More
Phase II trial shows safety and immunogenicity for Japanese encephalitis vaccine
Read More
SIGA advances ST-246 smallpox candidate development in Europe
Read More
Avapro obtains Japanese manufacturing and marketing approval
Read More
FDA grants fast track designation for RG-1068 in pancreatic imaging
Read More
FDA grants orphan drug designation for Zymenex's enzyme, Metazym
Read More
Insert initiates phase II clinical trial with lead drug candidate IT-101 for ovarian cancer
Read More
Novel antipsychotic YKP-1358 shows good safety and D2 receptor affinity in humans
Read More
MethylGene initiates phase I clinical trial for MGCD-265 in solid tumors
Read More
Novartis receives approval for Exjade in Japan
Read More
Ono and Dainippon Sumitomo discontinue limaprost in cervical spondylosis
Read More
Aldagen initiates treatment in phase III clinical trial of ALD-101 for cord blood transplants
Read More
New antiinflammatory agents reported in recent Nycomed patent
Read More
Novartis divulges novel S1P1 receptor agonists in recent patent
Read More